NeuroSense Therapeutics Ltd. Noncurrent Restricted Cash And Cash Equivalents
NeuroSense Therapeutics Ltd. (NRSN) had Noncurrent Restricted Cash And Cash Equivalents of $23.00 thousand as of 2023-06-30, per its 6-K filed 2023-08-16.
Discontinued › Notes
ifrs-full:NoncurrentRestrictedCashAndCashEquivalents · last filed 2023-08-16
- 2023-06-30: Noncurrent Restricted Cash And Cash Equivalents $23.00K.
- 2022-12-31: Noncurrent Restricted Cash And Cash Equivalents $23.00K.
| Period end | Noncurrent Restricted Cash And Cash Equivalents |
|---|---|
| 2023-06-30 | $23.00K 6-K · filed 2023-08-16 |
| 2022-12-31 | $23.00K 6-K · filed 2023-08-16 |